Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Other side effects Additional reported side effects include: Joint pain and water retention Muscle and joint aches Headaches and nausea Receptor desensitization with prolonged use Potential suppression of natural GH and IGF-1 production Who should avoid IGF-1 LR3 Certain groups should not use IGF-1 LR3: Anyone with active cancer or tumor history Those with severe insulin resistance or diabetes Pregnant or nursing women Anyone under 25 whose growth plates haven't closed Those with existing hormonal imbalances IGF-1 LR3 is not FDA-approved for general medical use and remains primarily a research compound
The primary outcomes of these trials were 3-point major adverse cardiovascular event (3-MACE) and the studies have together provided a wealth of data that, amongst others, have changed clinical guidelines
Multiply the GHK-Cu dose by the BAC water volume, then divide by the 50 mg of GHK-Cu in the vial
"Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure." National Library of Medicine
Author contributions SL, SM, Y-RL, JL, and H-GK contributed to the study conception and design
